China SXT Pharmaceuticals, Inc. (SXTC): Capital Expenditures

Annual figures by period end, from SEC filings.

$2.0K
Year ended 2025-03-31
-56.6%
5-year compound annual growth
$535.8K2017-03-31: $179.2K2018-03-31: $436.0K2019-03-31: $535.8K2020-03-31: $130.8K2024-03-31: $7.1K2025-03-31: $2.0K$2.0K
2017-03-31 Capital Expenditures (USD) 2025-03-31
Period endedCapital ExpendituresChange YoYSource filing
2025-03-31$2.0K-71.4%2026-07-01, From 2024-04-01
2024-03-31$7.1Kn/a2026-07-01, From 2023-04-01
No annual figure between 2020-03-31 and 2024-03-31.
2020-03-31$130.8K-75.6%2020-07-31, From 2019-04-01
2019-03-31$535.8K+22.9%2020-07-31, From 2018-04-01
2018-03-31$436.0K+143.3%2020-07-31, From 2017-04-01
2017-03-31$179.2Kn/a2019-08-15, From 2016-04-01